← All trials
NCT05788094
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 26, 2023
- Primary completion
- Feb 28, 2025
- Completion date
- Aug 31, 2025
- First posted
- Mar 28, 2023
- Last posted
- Oct 17, 2023
- Enrollment
- 388
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mahidol UniversityLead sponsor
- Mahidol UniversityCollaborator
- Mahidol UniversityOverall official - principal investigator
- Mahidol UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.